2012 annual financial data
Xenetic Biosciences 2012 Operating margin
Direct answer
Operating margin was -2,160.83%.
Operating income was -6.34M USD and net income was -6.33M USD.
Operating cash flow was -6.26M USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 293,603 USD
- Operating income
- -6.34M USD
- Net income
- -6.33M USD
- Operating cash flow
- -6.26M USD